Welcome to the UPF Digital Repository
Browsing by Author "Padilla, Eduardo"
- Home
- →
- Browsing by Author
JavaScript is disabled for your browser. Some features of this site may not work without it.
Browsing by Author "Padilla, Eduardo"
Now showing items 1-10 of 10
-
López Montesinos, Inmaculada; Gómez-Zorrilla, Silvia; Palacios-Baena, Zaira Raquel; Prim, Núria; Echeverría Esnal, Daniel; Gracia Arnillas, María Pilar; Montero, Maria Milagro; Duran Jordà, Xavier, 1974-; Sendra, Elena; Sorli Redó, M. Luisa; Güerri Fernández, Roberto; Padilla, Eduardo; Grau Cerrato, Santiago; Horcajada Gallego, Juan Pablo; PROA PSMAR group (SpringerOpen, 2022)Introduction: extensively drug-resistant (XDR) Pseudomonas aeruginosa (PA) infections are difficult to treat. We aimed to compare aminoglycosides or polymyxin monotherapy versus other antibiotic regimens (carbapenems, ...
-
Puig-Collderram, Berta; Domene Ochoa, Sandra; Salvà-Comas, Maria; Milagro Montero, Maria; Duran Jordà, Xavier, 1974-; González, Juan Ramón; Grau Cerrato, Santiago; Oliver, Antonio; Horcajada Gallego, Juan Pablo; Padilla, Eduardo; Segura, Concepción; Prim, Núria (American Society for Microbiology, 2022)Time-kill curves are used to study antibiotic combinations, but the colony count method to obtain the results is time-consuming. The aim of the study was to validate an ATP assay as an alternative to the conventional colony ...
-
Montero, Maria Milagro; Domene Ochoa, Sandra; López-Causapé, Carla; VanScoy, Brian; Luque Pardos, Sònia; Sorli Redó, M. Luisa; Campillo Ambrós, Núria; Padilla, Eduardo; Prim, Núria; Segura, Concepción; Pomar, Virginia; Rivera, Alba; Grau Cerrato, Santiago; Ambrose, Paul G.; Oliver, Antonio; Horcajada Gallego, Juan Pablo (Elsevier, 2019)Background: Extensively drug-resistant (XDR) Pseudomonas aeruginosa (P. aeruginosa) and particularly P. aeruginosa high-risk clones, are of growing concern because treatment options are limited. For years, colistin monotherapy ...
-
Montero, Maria Milagro; Domene Ochoa, Sandra; López-Causapé, Carla; López Montesinos, Inmaculada; Luque Pardos, Sònia; Sorli Redó, M. Luisa; Campillo Ambrós, Núria; Padilla, Eduardo; Prim, Núria; Ferrer Alapont, Lorena; Grau Cerrato, Santiago; Oliver, Antoni; Horcajada Gallego, Juan Pablo (ASM Press, 2022)The aim of this study was to compare the efficacy of intermittent (1-h), extended (4-h), and continuous ceftolozane-tazobactam (C/T) infusion against three extensively drug-resistant (XDR) sequence type (ST) 175 P. aeruginosa ...
-
Montero-Moraga, Jose Maria; Buron Pust, Andrea; Sala Serra, Maria; Santia, Paula; Lupia, Martina; Beltrán, Ana; Villar Vinuesa, Rocío, 1976-; Horcajada Gallego, Juan Pablo; Castells, Xavier; Díaz Gil, Oscar; Padilla, Eduardo; Serra, Consol (Wolters Kluwer (LWW), 2021)Objective: To describe the characteristics of COVID-19-related episodes in healthcare workers (HCW) of two hospitals. Methods: Prospective study of HCW with COVID-like symptoms and/or who were close contacts of confirmed ...
-
Montero, Maria Milagro; Domene Ochoa, Sandra; López-Causapé, Carla; Luque Pardos, Sònia; Sorlí, Luisa; Campillo Ambrós, Núria; Padilla, Eduardo; Prim, Núria; Ferrer Alapont, Lorena; Angulo-Brunet, Ariadna; Grau Cerrato, Santiago; Oliver, Antonio; Horcajada Gallego, Juan Pablo (Nature Research, 2021)Ceftolozane/tazobactam (C/T) has emerged as a potential agent for the treatment of extensively drug-resistant (XDR) Pseudomonas aeruginosa infections. As it is a time-dependent antimicrobial, prolonged infusion may help ...
-
Martínez-Casanova, Javier; Gómez-Zorrilla, Silvia; Prim, Núria; Molin, Agustina Dal; Echeverría Esnal, Daniel; Gracia Arnillas, María Pilar; Sendra, Elena; Güerri Fernández, Roberto; Duran Jordà, Xavier, 1974-; Padilla, Eduardo; Horcajada Gallego, Juan Pablo; Grau Cerrato, Santiago; PROA-PSMAR Group (MDPI, 2021)Background: High rates of amoxicillin-clavulanate (AMC) resistance among Enterobacterales isolated from urinary tract infections (UTIs) were observed in our area. The aim of this study was to identify risk factors associated ...
-
Grau Cerrato, Santiago; Ferrández, Olivia; Echeverría Esnal, Daniel; Maldonado, Rafael, 1961-; Puig, Berta; Ramirez, Aida; Canal, Mireia; Montero, Albert; González, Cristina; Herranz, Milagros; Masclans Enviz, Joan Ramon; Horcajada Gallego, Juan Pablo; Padilla, Eduardo (Wolters Kluwer Health, Inc., 2021)Our objective was to analyze in vitro the persistence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in the packaging material of the drugs dispensed to hospital wards. Additionally, to evaluate if the ...
-
López Montesinos, Inmaculada; Montero, Maria Milagro; Domene Ochoa, Sandra; López-Causapé, Carla; Echeverría Esnal, Daniel; Sorli Redó, M. Luisa; Campillo Ambrós, Núria; Luque Pardos, Sònia; Padilla, Eduardo; Prim, Núria; Grau Cerrato, Santiago; Oliver, Antonio; Horcajada Gallego, Juan Pablo (MDPI, 2022)This study correlates in vivo findings in a patient with an extensively drug-resistant (XDR) P. aeruginosa infection who developed resistance to ceftazidime-avibactam (CAZ-AVI) with in vitro results of a 7-day hollow-fiber ...
-
Montero, Maria Milagro; Domene Ochoa, Sandra; López-Causapé, Carla; Luque, Sonia; Sorlí, Luisa; Campillo Ambrós, Núria; López Montesinos, Inmaculada; Padilla, Eduardo; Prim, Núria; Angulo-Brunet, Ariadna; Grau Cerrato, Santiago; Oliver, Antoni; Horcajada Gallego, Juan Pablo (American Society for Microbiology, 2021)Ceftazidime-avibactam (CZA) has emerged as a promising solution to the lack of new antibiotics against Pseudomonas aeruginosa infections. Data from in vitro assays of CZA combinations, however, are scarce. The objective ...
Now showing items 1-10 of 10
© Universitat Pompeu Fabra | Plaça de la Mercè, 10-12. 08002 Barcelona | T. (+34) 93 542 20 00